SMARCA4 and non-small cell lung carcinoma: Accordingly, with the high percentage of smoker patients with SMARCA4-UT, there is a high frequency of p53 mutations and an overlap with smoker NSCLC abnormalities, such as mutations of serine/threonine kinase 11 (STK11), kelch-like ECH-associated protein (KEAP1), and KRAS [55] (Table 2).